Concepedia

Mari Fukushima‐Shintani

MF

Statistics

Publications

4

Citations

165

H-Index

4

Active since

2005

Affiliations

Kyoto University(Current)

Astellas Pharma (Japan)

Mari Fukushima‐Shintani is an author at Kyoto University specializing in cell biology, medicine, and hematology.

Top concepts

Publications per year

2005–2008

4

Publications

4

AKR‐501 (YM477) a novel orally‐active thrombopoietin receptor agonist

Mari Fukushima‐Shintani, Kenichi Suzuki, Yoshiyuki Iwatsuki et al. · European Journal Of Haematology · 2008 · 77 citations

, , +17

AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis

Mari Fukushima‐Shintani, Kenichi Suzuki, Yoshiyuki Iwatsuki et al. · Experimental Hematology · 2008 · 61 citations

, , +3

YM477, a Novel Orally-Active Thrombopoietin Receptor Agonist.

Kenichi Suzuki, Masaki Abe, Mari Fukushima‐Shintani et al. · Blood · 2005 · 16 citations

Efficient assay for evaluating human thrombopoiesis using NOD/SCID mice transplanted with cord blood CD34<sup>+</sup> cells

Kenichi Suzuki, Hidefumi Hiramatsu, Mari Fukushima‐Shintani et al. · European Journal Of Haematology · 2006 · 11 citations

1–4 of 4